{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:20:33Z","timestamp":1790320833206,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10549-016-4092-5","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T15:12:57Z","timestamp":1483110777000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients"],"prefix":"10.1007","volume":"162","author":[{"given":"Kazutaka","family":"Otsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kunita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fukayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"4092_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.critrevonc.2010.12.005","volume":"80","author":"CB Moelans","year":"2011","unstructured":"Moelans CB, de Weger RA, Van der Wall E et al (2011) Current technologies for HER2 testing in breast cancer. Crit Rev Oncol\/Hematol 80:380\u2013392. doi:\n                        10.1016\/j.critrevonc.2010.12.005","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"4092_CR2","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1073\/pnas.96.16.9236","volume":"96","author":"B Vogelstein","year":"1999","unstructured":"Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci 96:9236\u20139241. doi:\n                        10.1073\/pnas.96.16.9236","journal-title":"Proc Natl Acad Sci"},{"key":"4092_CR3","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1093\/nar\/gks203","volume":"40","author":"AS Whale","year":"2012","unstructured":"Whale AS, Huggett JF, Cowen S et al (2012) Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res 40:e82. doi:\n                        10.1093\/nar\/gks203","journal-title":"Nucleic Acids Res"},{"key":"4092_CR4","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604\u20138610. doi:\n                        10.1021\/ac202028g","journal-title":"Anal Chem"},{"key":"4092_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jviromet.2015.08.014","volume":"224","author":"SC Taylor","year":"2015","unstructured":"Taylor SC, Carbonneau J, Shelton DN et al (2015) Optimization of droplet digital PCR from RNA and DNA extracts with direct comparison to RT-qPCR: clinical implications for quantification of Oseltamivir-resistant subpopulations. J Virol Methods 224:58\u201366. doi:\n                        10.1016\/j.jviromet.2015.08.014","journal-title":"J Virol Methods"},{"key":"4092_CR6","doi-asserted-by":"publisher","first-page":"e0154430","DOI":"10.1371\/journal.pone.0154430","volume":"11","author":"K Matsusaka","year":"2016","unstructured":"Matsusaka K, Ishikawa S, Nakayama A (2016) Tumor content chart-assisted HER2\/CEP17 digital PCR analysis of gastric cancer biopsy specimens. PLoS ONE 11:e0154430. doi:\n                        10.1371\/journal.pone.0154430","journal-title":"PLoS ONE"},{"key":"4092_CR7","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013. doi:\n                        10.1200\/JCO.2013.50.9984","journal-title":"J Clin Oncol"},{"key":"4092_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118\u2013145. doi:\n                        10.1200\/JCO.2006.09.2775","journal-title":"J Clin Oncol"},{"key":"4092_CR9","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1158\/1078-0432.ccr-12-3768","volume":"19","author":"H Gevensleben","year":"2013","unstructured":"Gevensleben H, Garcia-Murillas I, Graeser MK et al (2013) Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clin Cancer Res 19:3276. doi:\n                        10.1158\/1078-0432.ccr-12-3768","journal-title":"Clin Cancer Res"},{"key":"4092_CR10","doi-asserted-by":"publisher","first-page":"e83409","DOI":"10.1371\/journal.pone.0083409","volume":"8","author":"I Garcia-Murillas","year":"2013","unstructured":"Garcia-Murillas I, Lambros M, Turner NC (2013) Determination of HER2 amplification status on tumour DNA by digital PCR. PLoS ONE 8:e83409. doi:\n                        10.1371\/journal.pone.0083409","journal-title":"PLoS ONE"},{"key":"4092_CR11","first-page":"605","volume":"28","author":"M Braun","year":"2013","unstructured":"Braun M, Kirsten R, Rupp NJ et al (2013) Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system. Histol Histopathol 28:605\u2013610","journal-title":"Histol Histopathol"},{"key":"4092_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1369\/0022155413516469","volume":"62","author":"N Nikolaishvilli-Feinberg","year":"2013","unstructured":"Nikolaishvilli-Feinberg N, Cohen SM, Midkiff B et al (2013) Development of DNA damage response signaling biomarkers using automated, quantitative image analysis. J Histochem Cytochem 62:185\u2013196. doi:\n                        10.1369\/0022155413516469","journal-title":"J Histochem Cytochem"},{"key":"4092_CR13","doi-asserted-by":"publisher","first-page":"30615","DOI":"10.18632\/oncotarget.5593","volume":"6","author":"P Fisel","year":"2015","unstructured":"Fisel P, St\u00fchler V, Bedke J et al (2015) MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma. Oncotarget 6:30615\u201330627. doi:\n                        10.18632\/oncotarget.5593","journal-title":"Oncotarget"},{"key":"4092_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.2013.49.7693","volume":"32","author":"Gagliato D Melo de","year":"2014","unstructured":"de Melo Gagliato D, Gonzalez-Angulo AM, Lei X et al (2014) Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 32:735\u2013744. doi:\n                        10.1200\/JCO.2013.49.7693","journal-title":"J Clin Oncol"},{"key":"4092_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","volume":"52","author":"M Hofmann","year":"2008","unstructured":"Hofmann M, Stoss O, Shi D et al (2008) Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 52:797\u2013805. doi:\n                        10.1111\/j.1365-2559.2008.03028.x","journal-title":"Histopathology"},{"key":"4092_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cncr.25580","volume":"117","author":"S Vranic","year":"2010","unstructured":"Vranic S, Teruya B, Repertinger S et al (2010) Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17. Cancer 117:48. doi:\n                        10.1002\/cncr.25580","journal-title":"Cancer"},{"key":"4092_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/modpathol.2013.103","volume":"27","author":"WM Hanna","year":"2013","unstructured":"Hanna WM, R\u00fcschoff J, Bilous M et al (2013) HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity. Mod Pathol 27:4. doi:\n                        10.1038\/modpathol.2013.103","journal-title":"Mod Pathol"},{"key":"4092_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/PDM.0b013e318064c72a","volume":"16","author":"RR Tubbs","year":"2007","unstructured":"Tubbs RR, Hicks DG, Cook J et al (2007) Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience. Diagn Mol Pathol 16:207\u2013210. doi:\n                        10.1097\/PDM.0b013e318064c72a","journal-title":"Diagn Mol Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4092-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T07:30:05Z","timestamp":1485934205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4092"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4092-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}